Abstract: A method includes receiving radar parameters from a unit under test (UUT). The method also includes generating a simulated radar return for the UUT using at least one graphics processing unit (GPU), where the simulated radar return includes digital signals. The method further includes controlling a timing of output of the simulated radar return to the UUT using at least one field programmable gate array (FPGA) carrier. The method also includes converting the digital signals into analog signals using multiple digital-to-analog converters (DACs). In addition, the method includes transmitting the analog signals to the UUT.

Abstract: A method includes receiving radar parameters from a unit under test (UUT). The method also includes generating a simulated radar return for the UUT using at least one graphics processing unit (GPU), where the simulated radar return includes digital signals. The method further includes controlling a timing of output of the simulated radar return to the UUT using at least one field programmable gate array (FPGA) carrier. The method also includes converting the digital signals into analog signals using multiple digital-to-analog converters (DACs). In addition, the method includes transmitting the analog signals to the UUT.

Abstract: Disclosed are various embodiments relating to verifying a printed work comprises a correct number of pages. Associated with a stack comprising one or more pages is an identifier that may be used to obtain an expected value for a physical characteristic of the pages in the stack. A sensor may then measure an actual value for the physical characteristic of the pages in the stack. Before binding the pages in the stack, the expected value may be compared to the actual value in order to verify the stack comprises the correct number of pages.

Abstract: A modular knee prosthesis system includes a femoral component having a stem and a sleeve. The system is modular, and provides the surgeon with the option of distally offsetting the joint line by controlling the relative axial positions of the stem and the sleeve. Alternative options include providing sleeves with tapered bores of different diameters, providing a shim to be placed between the sleeve and the stem and providing the stems as adapters having different diameters.

Abstract: Disclosed are various embodiments relating to verifying a printed work comprises a correct number of pages. Associated with a stack comprising one or more pages is an identifier that may be used to obtain an expected value for a physical characteristic of the pages in the stack. A sensor may then measure an actual value for the physical characteristic of the pages in the stack. Before binding the pages in the stack, the expected value may be compared to the actual value in order to verify the stack comprises the correct number of pages.

Abstract: Disclosed are various embodiments relating to verifying a printed work comprises a correct number of pages. Associated with a stack comprising one or more pages is an identifier that may be used to obtain an expected thickness of the pages in the stack. A sensor may then measure an actual thickness of the pages in the stack. Before binding the pages in the stack, the expected thickness of the stack may be compared to the actual thickness of the stack in order to verify the stack comprises the correct number of pages.

Abstract: A modular knee prosthesis system includes a femoral component having a stem and a sleeve. The system is modular, and provides the surgeon with the option of distally offsetting the joint line by controlling the relative axial positions of the stem and the sleeve. Alternative options include providing sleeves with tapered bores of different diameters, providing a shim to be placed between the sleeve and the stem and providing the stems as adapters having different diameters.

Abstract: The present invention is directed to retractor instrumentation for total hip arthroplasty, and methods of using same. In one illustrative embodiment, the device comprises a body, a first pin coupled to the body, and a second pin coupled to said body, wherein at least a portion of said first and second pins are adapted to penetrate human bone. In a further illustrative embodiment, a retractor instrumentation set comprises a retractor device, a shaft that is adapted to be removably coupled to the retractor device, and an inserter that is adapted to be removably coupled to the shaft.

Abstract: Disclosed are orally deliverable pharmaceutical compositions of 2′-deoxy-2′-(fluoromethylene)cytidine (“FMdC”) and methods for providing enhanced bioavailability of FMdC in vivo.

Abstract: Methods and compositions are provided for the treatment of a host suffering from a cellular proliferative disease. In the subject methods, antiproliferative agents are administered in a substantially non-aqueous gel delivery vehicle comprising at least one polar organic solvent in combination with one or more thickening agents. The subject methods and compositions provide for the enhanced efficacy of regionally or locally administered antiproliferative proliferative agents.

Abstract: Methods and compositions are provided for the treatment of a host suffering from a cellular proliferative disease. In the subject methods, antiproliferative agents are administered in a substantially non-aqueous gel delivery vehicle comprising at least one polar organic solvent in combination with one or more thickening agents. The subject methods and compositions provide for the enhanced efficacy of regionally or locally administered antiproliferative proliferative agents.

Abstract: Methods of treating cancer by administration of FMdC followed by administration of a platinate are disclosed.

Abstract: Methods and compositions are provided for the treatment of a host suffering from a cellular proliferative diease. In the subject methods, antiproliferative agents are administered in a substantially non-aqueous gel delivery vehicle comprising at least one polar organic solvent in combination with one or more thickening agents. The subject methods and compositions provide for the enhanced efficacy of regionally or locally administered antiproliferative proliferative agents.

Abstract: Methods and compositions are provided for the treatment of a host suffering from a cellular proliferative disease. In the subject methods, antiproliferative agents are administered in a substantially non-aqueous gel delivery vehicle comprising at least one polar organic solvent in combination with one or more thickening agents. The subject methods and compositions provide for the enhanced efficacy of regionally or locally administered antiproliferative proliferative agents.

Abstract: The present invention relates to tezacitabine ((E)-2′-fluoromethylene-2′-deoxycytidine) formulations which are stable for long periods of time. The present invention further relates to methods of formulating stable tezacitabine formulations.

Abstract: Methods of treating cancer by administration of FMdC followed by administration of a platinate are disclosed.

Abstract: Methods of treating cancer by administration of FMdC followed by administration of a platinate are disclosed.

Abstract: A disclosed walker is a three sided framework allowing quick connect/disconnect to the frame of a conventional standard wheelchair. The walker is formed with a front and two side assemblies pivotally linked to the front assembly. When the walker is not connected to a wheelchair, the side assemblies and front assemblies pivot and collapse into a “z” pattern forming a flat, compact package. For connection to a wheelchair, the sides assemblies unfold perpendicularly to the front assembly, and are locked into place by a horizontal crossbar. U-shaped securing clips located at the rear ends of the walker's side assemblies, drop over and straddle horizontal frame members of the wheelchair tightly grasping the wheelchair's frame members. The stability of the walker/wheelchair combination is enhanced by outward bends of the front vertical sections of the walker which terminate in swivel caster supports.

Abstract: Disclosed are orally deliverable pharmaceutical compositions of 2′-deoxy-2′-(fluoromethylene)cytidine (“FMdC”) and methods for providing enhanced bioavailability of FMdC in vivo.

Abstract: An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The suspension may be used directly, or may be used in preparing gel formulations for direct injection into a neoplastic lesion or surrounding tissue.